Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC

NCT04653480 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Surufatinib
DRUG: Toripalimab
DRUG: chemotherapy

Sponsor

Zhejiang University